Notably, in our model, tumor development only occurred in the presence of the ERBB2 mutants but not upon overexpression of the WT human ERBB2, further substantiating the notion that mutant ERBB2 is a more potent cancer driver than overexpression of WT ERBB2. Here, ERBB2 is linked to cancer.